Cargando…

Type I interferon underlies severe disease associated with Junín virus infection in mice

Junín virus (JUNV) is one of five New World mammarenaviruses (NWMs) that causes fatal hemorrhagic disease in humans and is the etiological agent of Argentine hemorrhagic fever (AHF). The pathogenesis underlying AHF is poorly understood; however, a prolonged, elevated interferon-α (IFN-α) response is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hickerson, Brady T, Sefing, Eric J, Bailey, Kevin W, Van Wettere, Arnaud J, Penichet, Manuel L, Gowen, Brian B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	eLife Sciences Publications, Ltd 2020
Materias:	Microbiology and Infectious Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7297529/ https://www.ncbi.nlm.nih.gov/pubmed/32452770 http://dx.doi.org/10.7554/eLife.55352

Ejemplares similares

Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial
por: Li, Chuan, et al.
Publicado: (2021)

Interferon receptor-deficient mice are susceptible to eschar-associated rickettsiosis
por: Burke, Thomas P, et al.
Publicado: (2021)

Host receptor-targeted therapeutic approach to counter pathogenic New World mammarenavirus infections
por: Hickerson, Brady T., et al.
Publicado: (2022)

Favipiravir (T-705) Inhibits Junín Virus Infection and Reduces Mortality in a Guinea Pig Model of Argentine Hemorrhagic Fever
por: Gowen, Brian B., et al.
Publicado: (2013)

A virus-packageable CRISPR screen identifies host factors mediating interferon inhibition of HIV
por: OhAinle, Molly, et al.
Publicado: (2018)

RIG-I Enhanced Interferon Independent Apoptosis upon Junin Virus Infection
por: Kolokoltsova, Olga A., et al.
Publicado: (2014)

For patients with rheumatic disease and hepatitis C infection: the end of interferon
por: Calabrese, Leonard H, et al.
Publicado: (2015)

Overexpression screen of interferon-stimulated genes identifies RARRES3 as a restrictor of Toxoplasma gondii infection
por: Rinkenberger, Nicholas, et al.
Publicado: (2021)

Dual signaling via interferon and DNA damage response elicits entrapment by giant PML nuclear bodies
por: Scherer, Myriam, et al.
Publicado: (2022)

Rotavirus VP3 targets MAVS for degradation to inhibit type III interferon expression in intestinal epithelial cells
por: Ding, Siyuan, et al.
Publicado: (2018)

Predicting outcome of patients with severe urinary tract infections admitted via the emergency department
por: Rothrock, Steven G., et al.
Publicado: (2020)

Severe infections emerge from commensal bacteria by adaptive evolution
por: Young, Bernadette C, et al.
Publicado: (2017)

Mycobacterium marinum Infection and Interferon-Gamma Release Assays Cross-Reactivity: A Case Report
por: Patel, Premalkumar M, et al.
Publicado: (2022)

Autophagy under attack
por: de Figueiredo, Paul, et al.
Publicado: (2016)

Human Leukocyte Antigen (HLA) Class I Susceptible Alleles Against COVID-19 Increase Both Infection and Severity Rate
por: Ishii, Tomoo
Publicado: (2020)

Potent Inhibition of Junín Virus Infection by Interferon in Murine Cells
por: Huang, Cheng, et al.
Publicado: (2014)

Junín Virus Infection Activates the Type I Interferon Pathway in a RIG-I-Dependent Manner
por: Huang, Cheng, et al.
Publicado: (2012)

MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters
por: Gowen, Brian B., et al.
Publicado: (2015)

Hepatitis C virus genotype analysis in patients with chronic hepatitis in North Eastern Bulgaria
por: Brady, Zarina, et al.
Publicado: (2019)

A Case Series of Secondary Spontaneous Pneumomediastinum and Pneumothorax in Severe COVID-19 Pneumonia
por: Staiano, Peter P, et al.
Publicado: (2022)

Factors associated with the severity of COVID‐19 outcomes in people with neuromuscular diseases: Data from the International Neuromuscular COVID‐19 Registry
por: Pizzamiglio, Chiara, et al.
Publicado: (2022)

Galidesivir limits Rift Valley fever virus infection and disease in Syrian golden hamsters
por: Westover, Jonna B., et al.
Publicado: (2018)

Membrane voltage dysregulation driven by metabolic dysfunction underlies bactericidal activity of aminoglycosides
por: Bruni, Giancarlo Noe, et al.
Publicado: (2020)

COVID‐19: A review of therapeutics under investigation
por: Crosby, James C., et al.
Publicado: (2020)

Single-Dose Intranasal Treatment with DEF201 (Adenovirus Vectored Consensus Interferon) Prevents Lethal Disease Due to Rift Valley Fever Virus Challenge
por: Gowen, Brian B., et al.
Publicado: (2014)

Predicting severe disease in patients diagnosed with seasonal influenza in the emergency department
por: Pajor, Michael J., et al.
Publicado: (2023)

The Incidence and Severity of COVID-19 in the Liverpool Severe Asthma Population Undergoing Biologic Therapy
por: Abdullah, Yahya
Publicado: (2022)

Evolutionarily distant I domains can functionally replace the essential ligand-binding domain of Plasmodium TRAP
por: Klug, Dennis, et al.
Publicado: (2020)

Pathogen clonal expansion underlies multiorgan dissemination and organ-specific outcomes during murine systemic infection
por: Hullahalli, Karthik, et al.
Publicado: (2021)

HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave
por: Karim, Farina, et al.
Publicado: (2021)

IL-6 and other biomarkers as predictors of severity in COVID-19
por: Broman, N., et al.
Publicado: (2021)

Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems
por: Silas, Sukrit, et al.
Publicado: (2017)

Evidence for the utility of cfDNA plasma concentrations to predict disease severity in COVID-19: a retrospective pilot study
por: Hoeter, Katharina, et al.
Publicado: (2023)

Vascular Leak and Hypercytokinemia Associated with Severe Fever with Thrombocytopenia Syndrome Virus Infection in Mice
por: Westover, Jonna B., et al.
Publicado: (2019)

Psychometric Validation of the Hepatitis C Symptom and Impact Questionnaire (HCV-SIQv4) in a Diverse Sample of Adults with Chronic Hepatitis C Virus Infection Treated with an Interferon-free Simeprevir-containing Regimen
por: Trigg, Andrew, et al.
Publicado: (2019)

Treatment delay affects clinical severity of tuberculosis: a longitudinal cohort study
por: Virenfeldt, J, et al.
Publicado: (2014)

Correction: Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems
por: Silas, Sukrit, et al.
Publicado: (2018)

COVID-19 Associated Coagulopathy in the Setting of Underlying Malignancy
por: Lim, Su Lin, et al.
Publicado: (2020)

Heavy isotope labeling and mass spectrometry reveal unexpected remodeling of bacterial cell wall expansion in response to drugs
por: Atze, Heiner, et al.
Publicado: (2022)

Randomised controlled trial to evaluate the effectiveness of using the RD-1-based C-Tb skin test as a replacement for blood-based interferon-γ release assay for detection of, and initiation of preventive treatment for, tuberculosis infection: RID-TB:Dx study protocol
por: Rangaka, Molebogeng X, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bscd89s1ij0vtospcs9a10o58h